Norton Rose Fulbright

Led from Houston by Brett Young and also able to draw upon resources from other key offices including Dallas and Minneapolis, Norton Rose Fulbright has significant visibility among pharmaceutical manufacturers and medical device companies, including in major class actions and MDLs. In Dallas, D’Lesli Davis , who heads up the life sciences and healthcare sub-group, has vast industry knowledge and litigation smarts with which she uses to good effect on MDLs/class actions, as well as in relation to pharmacovigilance matters. As well as regularly representing clients on personal injury matters, Davis has also gained a strong reputation advising on economic loss issues, not only on behalf of affected consumers but also third party payers. Also based in Dallas, Jonathan B. Skidmore regularly forms a pivotal part of the team’s involvement in many of the highest-profile disputes in the sector and has gained particular acclaim for his trial record. Dallas-based senior associate Ellie Norris is also recommended and has experience defending pharmaceutical manufacturers against economic loss, consumer protection, and deceptive practices claims brought by individuals, third-party payers, and state governments.